Saag, Kenneth G <br/><br/>
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  01 2019 
 - 143-153 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.40685  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Aspartate Aminotransferases--blood<br/>Colchicine--therapeutic use<br/>Cough--chemically induced<br/>Creatinine--blood<br/>Delayed-Action Preparations<br/>Diarrhea--chemically induced<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Febuxostat--administration & dosage<br/>Female<br/>Glomerular Filtration Rate<br/>Gout--blood<br/>Gout Suppressants--administration & dosage<br/>Headache--chemically induced<br/>Humans<br/>Hypertension--chemically induced<br/>Male<br/>Middle Aged<br/>Naproxen--therapeutic use<br/>Nasopharyngitis--chemically induced<br/>Renal Insufficiency, Chronic--complications<br/>Respiratory Tract Infections--chemically induced<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Uric Acid--blood<br/>gamma-Glutamyltransferase--blood